|
1
|
Torre LA, Bray F, Siegel RL, Ferlay J,
Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA
Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ward EM, DeSantis CE, Lin CC, Kramer JL,
Jemal A, Kohler B, Brawley OW and Gansler T: Cancer statistics:
Breast cancer in situ. CA Cancer J Clin. 65:481–495. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Safdari Y, Khalili M, Ebrahimzadeh MA,
Yazdani Y and Farajnia S: Natural inhibitors of PI3K/AKT signaling
in breast cancer: Emphasis on newly-discovered molecular mechanisms
of action. Pharmacol Res. 93:1–10. 2015. View Article : Google Scholar
|
|
4
|
Wu J, Yang G, Zhu W, Wen W, Zhang F, Yuan
J and An L: Anti-atherosclerotic activity of platycodin D derived
from roots of Platycodon grandiflorum in human endothelial cells.
Biol Pharm Bull. 35:1216–1221. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Chung JW, Noh EJ, Zhao HL, Sim JS, Ha YW,
Shin EM, Lee EB, Cheong CS and Kim YS: Anti-inflammatory activity
of prosapogenin methyl ester of platycodin D via nuclear
factor-kappaB pathway inhibition. Biol Pharm Bull. 31:2114–2120.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang T, Yang S, Du J, Jinfu Y and Shumin
W: Platycodin D attenuates airway inflammation in a mouse model of
allergic asthma by regulation NF-κB pathway. Inflammation.
38:1221–1228. 2015. View Article : Google Scholar
|
|
7
|
Zhao HL, Harding SV, Marinangeli CP, Kim
YS and Jones PJ: Hypocholesterolemic and anti-obesity effects of
saponins from Platycodon grandiflorum in hamsters fed atherogenic
diets. J Food Sci. 73:H195–H200. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lu Z, Wang L, Zhou R, Qiu Y, Yang L, Zhang
C, Cai M, Mi M and Xu H: Evaluation of the spermicidal and
contraceptive activity of Platycodin D, a Saponin from Platycodon
grandiflorum. PLoS One. 8:e820682013. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park JC, Lee YJ, Choi HY, Shin YK, Kim JD
and Ku SK: In vivo and in vitro antitumor effects of platycodin d,
a saponin purified from platycodi radix on the h520 lung cancer
cell. Evid Based Complement Alternat Med. 2014:4786532014.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li T, Xu WS, Wu GS, Chen XP, Wang YT and
Lu JJ: Platycodin D induces apoptosis, and inhibits adhesion,
migration and invasion in HepG2 hepatocellular carcinoma cells.
Asian Pac J Cancer Prev. 15:1745–1749. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chun J, Joo EJ, Kang M and Kim YS:
Platycodin D induces anoikis and caspase-mediated apoptosis via p38
MAPK in AGS human gastric cancer cells. J Cell Biochem.
114:456–470. 2013. View Article : Google Scholar
|
|
12
|
Zhou R, Lu Z, Liu K, Guo J, Liu J, Zhou Y,
Yang J, Mi M and Xu H: Platycodin D induces tumor growth arrest by
activating FOXO3a expression in prostate cancer in vitro and in
vivo. Curr Cancer Drug Targets. 14:860–871. 2015. View Article : Google Scholar
|
|
13
|
Kim MO, Moon DO, Choi YH, Shin DY, Kang
HS, Choi BT, Lee JD, Li W and Kim GY: Platycodin D induces
apoptosis and decreases telomerase activity in human leukemia
cells. Cancer Lett. 261:98–107. 2008. View Article : Google Scholar
|
|
14
|
Kim MO, Moon DO, Choi YH, Lee JD, Kim ND
and Kim GY: Platycodin D induces mitotic arrest in vitro, leading
to endoredu-plication, inhibition of proliferation and apoptosis in
leukemia cells. Int J Cancer. 122:2674–2681. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chun J and Kim YS: Platycodin D inhibits
migration, invasion, and growth of MDA-MB-231 human breast cancer
cells via suppression of EGFR-mediated Akt and MAPK pathways. Chem
Biol Interact. 205:212–221. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Yu JS and Kim AK: Platycodin D induces
apoptosis in MCF-7 human breast cancer cells. J Med Food.
13:298–305. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ye Y, Han X, Guo B, Sun Z and Liu S:
Combination treatment with platycodin D and osthole inhibits cell
proliferation and invasion in mammary carcinoma cell lines. Environ
Toxicol Pharmacol. 36:115–124. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fakharzadeh SS, Trusko SP and George DL:
Tumorigenic potential associated with enhanced expression of a gene
that is amplified in a mouse tumor cell line. EMBO J. 10:1565–1569.
1991.PubMed/NCBI
|
|
19
|
Rayburn ER, Ezell SJ and Zhang R: Recent
advances in validating MDM2 as a cancer target. Anticancer Agents
Med Chem. 9:882–903. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Onel K and Cordon-Cardo C: MDM2 and
prognosis. Mol Cancer Res. 2:1–8. 2004.PubMed/NCBI
|
|
21
|
Nag S, Qin J, Srivenugopal KS, Wang M and
Zhang R: The MDM2-p53 pathway revisited. J Biomed Res. 27:254–271.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Brosh R and Rotter V: When mutants gain
new powers: News from the mutant p53 field. Nat Rev Cancer.
9:701–713. 2009.PubMed/NCBI
|
|
23
|
Epstein CB, Attiyeh EF, Hobson DA, Silver
AL, Broach JR and Levine AJ: p53 mutations isolated in yeast based
on loss of transcription factor activity: Similarities and
differences from p53 mutations detected in human tumors. Oncogene.
16:2115–2122. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Lee SK, Park KK, Kim HJ, Kim KR, Kang EJ,
Kim YL, Yoon H, Kim YS and Chung WY: Platycodin D blocks breast
cancer-induced bone destruction by inhibiting osteoclastogenesis
and the growth of breast cancer cells. Cell Physiol Biochem.
36:1809–1820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Tang ZH, Li T, Gao HW, Sun W, Chen XP,
Wang YT and Lu JJ: Platycodin D from Platycodonis Radix enhances
the anti-proliferative effects of doxorubicin on breast cancer
MCF-7 and MDA-MB-231 cells. Chin Med. 9:162014. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chun J, Ha IJ and Kim YS:
Antiproliferative and apoptotic activities of triterpenoid saponins
from the roots of Platycodon grandiflorum and their
structure-activity relationships. Planta Med. 79:639–645. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Riley T, Sontag E, Chen P and Levine A:
Transcriptional control of human p53-regulated genes. Nat Rev Mol
Cell Biol. 9:402–412. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hao Q and Cho WC: Battle against cancer:
An everlasting saga of p53. Int J Mol Sci. 15:22109–22127. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Muller PA and Vousden KH: p53 mutations in
cancer. Nat Cell Biol. 15:2–8. 2013. View Article : Google Scholar
|
|
30
|
Hollstein M, Sidransky D, Vogelstein B and
Harris CC: p53 mutations in human cancers. Science. 253:49–53.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Freed-Pastor WA and Prives C: Mutant p53:
One name, many proteins. Genes Dev. 26:1268–1286. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Rivlin N, Brosh R, Oren M and Rotter V:
Mutations in the p53 tumor suppressor gene: Important milestones at
the various steps of tumorigenesis. Genes Cancer. 2:466–474. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Kim BM, Kim DH, Park JH, Surh YJ and Na
HK: Ginsenoside Rg3 inhibits constitutive activation of NF-κB
signaling in human breast cancer (MDA-MB-231) cells: ERK and Akt as
potential upstream targets. J Cancer Prev. 19:23–30. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Zhang Q, Zeng SX and Lu H: Targeting
p53-MDM2-MDMX loop for cancer therapy. Subcell Biochem. 85:281–319.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Pei D, Zhang Y and Zheng J: Regulation of
p53: A collaboration between Mdm2 and Mdmx. Oncotarget. 3:228–235.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Qin JJ, Wang W, Voruganti S, Wang H, Zhang
WD and Zhang R: Identification of a new class of natural product
MDM2 inhibitor: In vitro and in vivo anti-breast cancer activities
and target validation. Oncotarget. 6:2623–2640. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Olivier M, Eeles R, Hollstein M, Khan MA,
Harris CC and Hainaut P: The IARC TP53 database: New online
mutation analysis and recommendations to users. Hum Mutat.
19:607–614. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Katayose D, Gudas J, Nguyen H, Srivastava
S, Cowan KH and Seth P: Cytotoxic effects of adenovirus-mediated
wild-type p53 protein expression in normal and tumor mammary
epithelial cells. Clin Cancer Res. 1:889–897. 1995.PubMed/NCBI
|
|
39
|
Walerych D, Napoli M, Collavin L and Del
Sal G: The rebel angel: Mutant p53 as the driving oncogene in
breast cancer. Carcinogenesis. 33:2007–2017. 2012. View Article : Google Scholar : PubMed/NCBI
|
